CD276 and diffuse intrinsic pontine glioma: The first report of intracranial B7-H3 CAR T cells being repeatedly dosed in patients with diffuse intrinsic pontine glioma indicated preliminary findings on tolerability, the presence of CAR T cells in the CSF, and CSF cytokine elevations that suggested locoregional immune activation [72].